Financhill
Back

Athira Pharma Quote, Financials, Valuation and Earnings

Buy
63

ATHA
Athira Pharma

Last Price:
2.54
Seasonality Move:
-34.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Athira Pharma Price Quote

$2.54
+0.02 (+-6.27%)
(Updated: May 18, 2024 at 5:37 AM ET)

Athira Pharma Key Stats

Buy
63
Athira Pharma (ATHA) is a Buy

Day range:
$2.46 - $2.70
52-week range:
$1.33 - $4.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.9%

Volume:
180.1K
Avg. volume:
171.4K
1-year change:
-8.7%
Market cap:
$96.6M
Revenue:
$0
EPS:
$-3.05

How Much Does Athira Pharma Make?

Data Unavailable

Is Athira Pharma Growing As A Company?

Data Unavailable

Athira Pharma Stock Price Performance

  • Did Athira Pharma Stock Go Up Last Month?
    Athira Pharma share price went up by 19.43% last month
  • Did ATHA's Share Price Rise Over The Last Year?
    ATHA share price fell by -8.7% over the past 1 year

What Is Athira Pharma 52-Week High & Low?

Athira Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Athira Pharma?

  • How Much Debt Does Athira Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Athira Pharma Have?
    Cash and short term investments quarterly total is $122.1M
  • What Is Athira Pharma’s Book Value Per Share?
    Book value per share is 2.79

Is Athira Pharma Cash Flow Positive?

  • What Is ATHA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$100.4M
  • What Is Athira Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $394K
  • What Is Athira Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $72.6M

Athira Pharma Return On Invested Capital

Data Unavailable

Athira Pharma Earnings Date & Stock Price

Athira Pharma Competitors

  • Who Are Athira Pharma's Competitors?
    Below is a list of companies who compete with Athira Pharma or are related in some way:
    • Arcutis Biotherapeutics Inc (ARQT)
    • Inozyme Pharma Inc (INZY)
    • Kodiak Sciences Inc (KOD)
    • Phathom Pharmaceuticals Inc (PHAT)
    • Xeris Biopharma Holdings Inc (XERS)

Athira Pharma Dividend Yield

Data Unavailable

Athira Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 7.28
Upside from Last Price: 188.69%

Major Shareholders

  • How many ATHA shares are owned by institutional investors?
    23.8M ATHA shares are owned by institutional investors
  • How many ATHA shares are owned by insiders?
    1.9M ATHA shares are owned by insiders